SCOTT C SCHMIDT

Allopathic & Osteopathic Physicians|Family Medicine AUBURN, CA NPI 1114599313

General Payments — all program years on this page

$496.26

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 22
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $483.93 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $483.9321

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2022 $12.331
2024 $483.9321

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077919041 Janssen Pharmaceuticals, Inc $16.59 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086129168 Bayer Healthcare Pharmaceuticals Inc. $32.42 10/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097148785 Novo Nordisk Inc $22.41 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097212209 Novo Nordisk Inc $23.99 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097280869 Novo Nordisk Inc $22.76 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097411311 Novo Nordisk Inc $20.66 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097713613 Novo Nordisk Inc $31.01 11/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114434661 Exact Sciences Corporation $31.41 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114434665 Exact Sciences Corporation $29.22 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116086922 GlaxoSmithKline, LLC. $22.77 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131533590 PFIZER INC. $18.08 11/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131543273 PFIZER INC. $15.03 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131561994 PFIZER INC. $15.16 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135305897 Collegium Pharmaceutical, Inc. $21.91 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135381011 Lilly USA, LLC $18.39 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135410307 Lilly USA, LLC $24.95 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143315122 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $25.88 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144181481 Madrigal Pharmaceuticals $26.81 10/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146991314 AIMMUNE THERAPEUTICS, INC. $19.93 11/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153649760 Salix Pharmaceuticals, a division of Bausch Health US, LLC $24.25 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154174873 HEARTFLOW, INC. $20.30 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.